Wikisage, the free encyclopedia of the second generation, is digital heritage

Levetiracetam: Difference between revisions

From Wikisage
Jump to navigation Jump to search
m (dutch todo)
Line 3: Line 3:
[http://www.fda.gov/downloads/Drugs/DrugSafety/UCM312880.pdf Medication guide FDA]
[http://www.fda.gov/downloads/Drugs/DrugSafety/UCM312880.pdf Medication guide FDA]
==Links==
==Links==
In mioclonic astatic epilepsy should be used with caution in children<ref>Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy. BMC paeditrics</ref>
===ATC===
===ATC===
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5

Revision as of 00:23, 30 March 2016

(S)-2-(2-Oxopyrrolidin-1-yl)butanamide is an anticonvulsant medication used to treat epilepsy. It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.

Extended release

Medication guide FDA

Links

In mioclonic astatic epilepsy should be used with caution in children[1]

ATC

levetiracetam
[2]

Trinka E., et al 2015 Pharmacotherapy for Status Epilepticus Drugs 75:1499


Safraski J.-P.2015

Jackson J.-L. et al.2015

Q417227 at Wikidata  Interwiki via Wikidata


  1. Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy. BMC paeditrics
  2. http://www.whocc.no/atc_ddd_index/?code=N03AX14&showdescription=yes